Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite Using Citrate- vs Acetate-based Dialysate (HEMODIACIDE)
Intradialytic Hypotension
About this trial
This is an interventional other trial for Intradialytic Hypotension focused on measuring citrate based dialysate, acetate based dialysate, hypotension, hemodynamic tolerance
Eligibility Criteria
Inclusion Criteria: Patient ≥ 18 years old Patient hospitalized in an intensive care unit Patient with acute renal failure defined by a KDIGO stage ≥ 1 and suspected non-obstructive Patient at risk of per dialytic hypotension (capillary refill time ≥ 3 seconds and/or cardiovascular SOFA ≥ 1 and/or lactatemia > 2) Indication for Extra Renal Replacement Therapy with IHD. Exclusion Criteria: Pregnant or breastfeeding woman Known chronic renal insufficiency of any stage Cardio-renal and hepato renal syndrome Unstable hemodynamic state: refractory shock Patient included in another interventional study likely to modify the hemodynamic state Patient deprived of liberty Patient under guardianship or curatorship Patient not affiliated to a social security system
Sites / Locations
- Centre Hospitalier Béthune
- Centre Hospitalier Universitaire de Caen
Arms of the Study
Arm 1
Arm 2
Other
Experimental
Control group
Experimental group
Using acetate-based dialysate
Using citrate-based dialysate